| A scoping review of studies comparing the medication event monitoring system (MEMS) with alternative methods for measuring medication adherence M El Alili, B Vrijens, J Demonceau, SM Evers, M Hiligsmann British journal of clinical pharmacology 82 (1), 268-279, 2016 | 210 | 2016 |
| Effect of single‐versus double‐layer uterine closure during caesarean section on postmenstrual spotting (2Close): multicentre, double‐blind, randomised controlled superiority trial SI Stegwee, LF Van Der Voet, AJ Ben, RA De Leeuw, PM Van De Ven, ... BJOG: An International Journal of Obstetrics & Gynaecology 128 (5), 866-878, 2021 | 56 | 2021 |
| The statistical approach in trial-based economic evaluations matters: get your statistics together! EN Mutubuki, M El Alili, JE Bosmans, T Oosterhuis, F J. Snoek, ... BMC health services research 21 (1), 475, 2021 | 36 | 2021 |
| Taking the analysis of trial-based economic evaluations to the next level: the importance of accounting for clustering M El Alili, JM van Dongen, KS Goldfeld, MW Heymans, MW van Tulder, ... Pharmacoeconomics 38, 1247-1261, 2020 | 30 | 2020 |
| A scoping review of statistical methods for trial‐based economic evaluations: The current state of play M El Alili, JM van Dongen, JL Esser, MW Heymans, MW van Tulder, ... Health Economics 31 (12), 2680-2699, 2022 | 22 | 2022 |
| Cost-effectiveness of the Namaste care family program for nursing home residents with advanced dementia in comparison with usual care: a cluster-randomized controlled trial M El Alili, HJA Smaling, KJ Joling, WP Achterberg, AL Francke, ... BMC health services research 20, 1-11, 2020 | 22 | 2020 |
| Reporting and analysis of trial-based cost-effectiveness evaluations in obstetrics and gynaecology M El Alili, JM van Dongen, JAF Huirne, MW van Tulder, JE Bosmans Pharmacoeconomics 35, 1007-1033, 2017 | 18 | 2017 |
| What do national pharmacoeconomic guidelines recommend regarding the statistical analysis of trial-based economic evaluations? JM van Dongen, M El Alili, AN Varga, AE Guevara Morel, A Jornada Ben, ... Expert review of pharmacoeconomics & outcomes research 20 (1), 27-37, 2020 | 15 | 2020 |
| Cost-effectiveness of SGLT2 inhibitors in a real-world population: a MICADO model-based analysis using routine data from a GP registry X Li, R Hoogenveen, M El Alili, S Knies, J Wang, JWJ Beulens, ... Pharmacoeconomics 41 (10), 1249-1262, 2023 | 10 | 2023 |
| Economic evaluation of a combined screening and stepped-care treatment program targeting psychological distress in patients with metastatic colorectal cancer: a cluster … M El Alili, CSEW Schuurhuizen, AMJ Braamse, ATF Beekman, ... Palliative medicine 34 (7), 934-945, 2020 | 10 | 2020 |
| Conducting trial-based economic evaluations using R: a tutorial ÂJ Ben, JM van Dongen, M El Alili, JL Esser, HM Broulíková, JE Bosmans Pharmacoeconomics 41 (11), 1403-1413, 2023 | 9 | 2023 |
| Cost-effectiveness and return-on-investment of C-reactive protein point-of-care testing in comparison with usual care to reduce antibiotic prescribing for lower respiratory … TM Boere, M El Alili, LW van Buul, RM Hopstaken, TJM Verheij, ... BMJ open 12 (9), e055234, 2022 | 7 | 2022 |
| The handling of missing data in trial-based economic evaluations: should data be multiply imputed prior to longitudinal linear mixed-model analyses? ÂJ Ben, JM van Dongen, ME Alili, MW Heymans, JWR Twisk, ... The European Journal of Health Economics 24 (6), 951-965, 2023 | 6 | 2023 |
| Cost-effectiveness and cost-utility of add-on, low-dose prednisolone in patients with rheumatoid arthritis aged 65+: The pragmatic, multicenter, placebo-controlled GLORIA trial L Hartman, M El Alili, M Cutolo, D Opris, JAP Da Silva, Z Szekanecz, ... Seminars in Arthritis and Rheumatism 57, 152109, 2022 | 5 | 2022 |
| Cost-effectiveness of custom-made insoles versus usual care in patients with plantar heel pain in primary care: cost-effectiveness analysis of a randomised controlled trial N Rasenberg, M Van Middelkoop, SMA Bierma-Zeinstra, M El Alili, ... BMJ open 11 (11), e051866, 2021 | 5 | 2021 |
| Cost-effectiveness of twice-weekly versus once-weekly sessions of cognitive–behavioural therapy and interpersonal psychotherapy for depression at 12 months after start of … JE Bosmans, SJE Bruijniks, M El Alili, SD Hollon, FPML Peeters, A Arntz, ... BJPsych Open 9 (6), e186, 2023 | 2 | 2023 |
| Cost-effectiveness of single-layer versus double-layer uterine closure during caesarean section on postmenstrual spotting: economic evaluation alongside a randomised controlled … SI Stegwee, ÂJ Ben, M El Alili, LF van der Voet, CJM de Groot, ... BMJ open 11 (7), e044340, 2021 | 2 | 2021 |
| Mapping Oswestry Disability Index Responses to EQ-5D-3L Utility Values: Are Cost-Utility Results Valid? ÂJ Ben, S Pellekooren, JE Bosmans, RWJG Ostelo, ET Maas, M El Alili, ... Value in Health 26 (6), 873-882, 2023 | 1 | 2023 |
| Cost-effectiveness of the SMILE intervention compared with usual care for people with severe mental illness: A randomized clinical trial M El Alili, B van Meijel, MW van Tulder, M Adriaanse PloS one 20 (1), e0313100, 2025 | | 2025 |
| Cost-effectiveness of general practitioner-versus surgeon-led colon cancer survivorship care: an economic evaluation alongside a randomised controlled trial JAM Vos, M El Alili, LAM Duineveld, T Wieldraaijer, J Wind, E Sert, ... Journal of Cancer Survivorship 18 (4), 1393-1402, 2024 | | 2024 |